Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Campine nv | CAMB | Mar 28, 2024 | 67.00 | -0.74 |
Candela Invest | CAND | Mar 28, 2024 | 2.90 | 0.00 |
Care Property Invest NV/SA | CPINV | Mar 28, 2024 | 13.20 | +3.45 |
Celyad Oncology SA | CYAD | Mar 28, 2024 | 0.35 | -1.13 |
Cenergy Holdings | CENER | Mar 28, 2024 | 7.29 | +2.10 |
Chevron | CHTEX | Mar 28, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Mar 28, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Mar 28, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Mar 28, 2024 | 60.65 | +2.62 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Mar 28, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Mar 28, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Mar 28, 2024 | 42.82 | -1.20 |
Compagnie du Bois Sauvage S.A. | COMB | Mar 28, 2024 | 247.00 | +1.23 |
Compagnie d`Entreprises CFE SA | CFEB | Mar 28, 2024 | 7.16 | -0.97 |
Connect Group | CONN | Mar 28, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Mar 28, 2024 | 0.01 | 0.00 |
Cumulex NV | CLEX | Mar 28, 2024 | 1.01 | 0.00 |
CURETIS | CURE | Mar 28, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | Mar 28, 2024 | 2.25 | +0.67 |
Deme Group N.V. | DEME | Mar 28, 2024 | 148.20 | +5.41 |
Deutsche Telekom AG | DTEL | Mar 28, 2024 | 20.00 | 0.00 |
Dexia SA | DEXB | Mar 28, 2024 | 0.30 | 0.00 |
Diegem KennedyCert | DIEG | Mar 28, 2024 | 120.00 | 0.00 |
Distri Land Le Certificat Foncier | DISL | Mar 28, 2024 | 197.00 | 0.00 |
DMS Imaging SA | ALIMG | Mar 28, 2024 | 0.02 | +8.33 |
DMS Imaging SA | DMSIM | Mar 28, 2024 | 0.02 | 0.00 |
D`ieteren Group | DIE | Mar 28, 2024 | 205.60 | -0.10 |
E. On SE | EON | Mar 28, 2024 | 11.32 | 0.00 |
Eckert & Ziegler BEBIG SA | EZBG | 0.00 | 0.00 | |
Econocom Group SE | ECONB | Mar 28, 2024 | 2.13 | +0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.